1-150364893-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001387123.1(RPRD2):c.-352A>G variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.0000198 in 1,461,672 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.000020 ( 1 hom. )
Consequence
RPRD2
NM_001387123.1 5_prime_UTR_premature_start_codon_gain
NM_001387123.1 5_prime_UTR_premature_start_codon_gain
Scores
7
12
Clinical Significance
Conservation
PhyloP100: 4.66
Genes affected
RPRD2 (HGNC:29039): (regulation of nuclear pre-mRNA domain containing 2) Predicted to enable RNA polymerase II complex binding activity. Predicted to be involved in mRNA 3'-end processing. Part of RNA polymerase II, holoenzyme. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.3068264).
BS2
High AC in GnomAdExome4 at 29 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPRD2 | NM_015203.5 | c.179A>G | p.Tyr60Cys | missense_variant | 1/11 | ENST00000369068.5 | NP_056018.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPRD2 | ENST00000369068.5 | c.179A>G | p.Tyr60Cys | missense_variant | 1/11 | 1 | NM_015203.5 | ENSP00000358064.4 | ||
RPRD2 | ENST00000401000.8 | c.179A>G | p.Tyr60Cys | missense_variant | 1/10 | 1 | ENSP00000383785.4 | |||
RPRD2 | ENST00000369067.7 | c.179A>G | p.Tyr60Cys | missense_variant | 1/3 | 2 | ENSP00000358063.3 | |||
RPRD2 | ENST00000492220.1 | n.308+1495A>G | intron_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.0000198 AC: 29AN: 1461672Hom.: 1 Cov.: 32 AF XY: 0.0000193 AC XY: 14AN XY: 727118
GnomAD4 exome
AF:
AC:
29
AN:
1461672
Hom.:
Cov.:
32
AF XY:
AC XY:
14
AN XY:
727118
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 22, 2023 | The c.179A>G (p.Y60C) alteration is located in exon 1 (coding exon 1) of the RPRD2 gene. This alteration results from a A to G substitution at nucleotide position 179, causing the tyrosine (Y) at amino acid position 60 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N;D;N
REVEL
Benign
Sift
Uncertain
D;T;D
Sift4G
Benign
T;T;T
Polyphen
D;.;D
Vest4
MutPred
Loss of MoRF binding (P = 0.0945);Loss of MoRF binding (P = 0.0945);Loss of MoRF binding (P = 0.0945);
MVP
MPC
0.90
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at